1. Home
  2. AYTU vs ADN Comparison

AYTU vs ADN Comparison

Compare AYTU & ADN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • ADN
  • Stock Information
  • Founded
  • AYTU N/A
  • ADN 2006
  • Country
  • AYTU United States
  • ADN United States
  • Employees
  • AYTU N/A
  • ADN N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • ADN Power Generation
  • Sector
  • AYTU Health Care
  • ADN Utilities
  • Exchange
  • AYTU Nasdaq
  • ADN Nasdaq
  • Market Cap
  • AYTU 8.3M
  • ADN 7.5M
  • IPO Year
  • AYTU N/A
  • ADN N/A
  • Fundamental
  • Price
  • AYTU $1.10
  • ADN $1.95
  • Analyst Decision
  • AYTU
  • ADN
  • Analyst Count
  • AYTU 0
  • ADN 0
  • Target Price
  • AYTU N/A
  • ADN N/A
  • AVG Volume (30 Days)
  • AYTU 30.8K
  • ADN 21.2K
  • Earning Date
  • AYTU 05-14-2025
  • ADN 12-27-2024
  • Dividend Yield
  • AYTU N/A
  • ADN N/A
  • EPS Growth
  • AYTU N/A
  • ADN N/A
  • EPS
  • AYTU N/A
  • ADN N/A
  • Revenue
  • AYTU $77,232,000.00
  • ADN $8,157,000.00
  • Revenue This Year
  • AYTU N/A
  • ADN $2,232.99
  • Revenue Next Year
  • AYTU $8.14
  • ADN $91.56
  • P/E Ratio
  • AYTU N/A
  • ADN N/A
  • Revenue Growth
  • AYTU N/A
  • ADN 274.35
  • 52 Week Low
  • AYTU $0.95
  • ADN $1.71
  • 52 Week High
  • AYTU $3.45
  • ADN $8.79
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 42.38
  • ADN 22.88
  • Support Level
  • AYTU $0.99
  • ADN $2.49
  • Resistance Level
  • AYTU $1.10
  • ADN $2.84
  • Average True Range (ATR)
  • AYTU 0.08
  • ADN 0.32
  • MACD
  • AYTU 0.01
  • ADN -0.07
  • Stochastic Oscillator
  • AYTU 50.00
  • ADN 0.00

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

About ADN Advent Technologies Holdings Inc.

Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.

Share on Social Networks: